Product: Women’s and Children’s Health Technology Fund

Company: Cross-Border Impact Ventures

About the Product:

Cross-Border Impact Ventures is an impact venture capital firm on a mission to revolutionize venture investing in health technology. Through the Women's and Children's Health Technology Fund I and II, Cross-Border Impact Ventures invests in early-growth stage health technology companies commercializing medical devices, diagnostic tools, digital therapeutics and digital health solutions leveraging cutting-edge technologies like Artificial Intelligence (AI) and Machine Learning (ML). All innovations the Fund finances are relevant to women’s, children’s, and adolescents’ health and located in North America and Europe, with the ability to scale technologies to emerging markets. Cross-Border Impact Ventures is driven by the belief that good health should not be restricted by gender, age, race, wealth, or borders, and seeks to expand access to its portfolio’s world-class technologies inclusively and globally.

Product: Mayo Clinic / Mayo Clinic and Arizona State University Alliance for Health Care Accelerator

Company: Mayo Foundation for Medical Education and Research

About the Product:

Where Innovation Meets Impact in Health Care. The Mayo Clinic and ASU Alliance for Health Care Accelerator is a pioneering collaboration that unites the clinical excellence of Mayo Clinic with the innovation ecosystem of Arizona State University. Designed to accelerate breakthroughs in healthcare products, services and solutions, the program offers unparalleled access to clinical validation, expert mentorship, and a robust commercialization pathway. Startups benefit from direct engagement with world-renowned clinicians, regulatory experts, and venture capital networks. This accelerator transforms visionary ideas into life-saving solutions, empowering healthcare innovators to scale with purpose and precision. This one-of-a-kind collaboration exemplifi

Product: The Activator

Company: Nucleate

About the Product:

The Nucleate Activator is a free, equity-free accelerator supporting scientist-entrepreneurs at the earliest stages of biotech company formation. Operating across 40 chapters in 20+ countries, the Activator provides co-founder matching, expert mentorship, hands-on workshops, and investor access to founders sourced directly from 400+ academic institutions — before most programs will engage with them. Since 2019, Activator alumni have incorporated 300+ companies, raised $670M in capital, and created 900+ jobs. Partners include Eli Lilly, Pillar VC, Genentech, and Alnylam Pharmaceuticals. The Activator removes financial and geographic barriers to biotech company creation with no fees, no equity, and no prerequisites.